Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
Zenyth: Feasibility and Acceptability of an Motivational Interviewing (MI)-Based Telehealth Intervention for Bacterial Sexually Transmitted Infection (STI) Screening
2 other identifiers
interventional
75
1 country
1
Brief Summary
In the United States (US), gay and bisexual men living with human immunodeficiency virus (HIV) bear a heavy burden of bacterial sexually transmitted infections (STIs) such as gonorrhea, chlamydia, and syphilis. It is important to diagnose and treat STIs in a timely manner to prevent health complications and reduce transmissions. The purpose of this study is to understand whether gay and bisexual men living with HIV are willing to collect and return specimens for bacterial STI testing when combined with live audio/video (AV) conferencing support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedStudy Start
First participant enrolled
April 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2025
CompletedResults Posted
Study results publicly available
July 1, 2025
CompletedJuly 1, 2025
June 1, 2025
11 months
October 20, 2023
May 28, 2025
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Number of Participants That Schedule a Pre-test Session
Up to 8 weeks after participants complete the baseline survey
Number of Participants That Join the Pre-test Session Within 30 Minutes of the Start Time
Up to 8 weeks after participants complete the baseline survey
Number of Participants That Return Each Type of Specimen Within 6 Weeks of Box Delivery
Up to 16 weeks after participants complete the baseline survey
Number of Participants That Provide Specimens of Adequate Quality for Lab Testing
Up to 16 weeks after participants complete the baseline survey
Number of Participants That Schedule a Post-test Session
Up to 24 weeks after participants complete the baseline survey
Number of Participants That Join the Post-test Session Within 30 Minutes of the Start Time
Up to 24 weeks after participants complete the baseline survey
Overall Intervention Satisfaction
Participants' satisfaction with the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater overall intervention satisfaction.
Up to 32 weeks after participants complete the baseline survey
Interventionist Perceptions
Participants' perceptions of the interventionist conducting the pre-test and the post-test sessions will be assessed using two 12-item Counselor Rating Form Short scales included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 24-168, with higher scores indicating more positive interventionist perceptions.
Up to 32 weeks after participants complete the baseline survey
Usability of the Pre-test and the Post-test Sessions
Participants' usability of the pre-test and the post-test sessions will be assessed using two 4-item subscales from the Telehealth Usability Questionnaire on the quality of interactions with the interventionist during each session included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 8-56, with higher scores indicating greater usability of the pre-test and the post-test sessions.
Up to 32 weeks after participants complete the baseline survey
Willingness to Repeat the Intervention
Participants' willingness to repeat the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater willingness to repeat the intervention.
Up to 32 weeks after participants complete the baseline survey
Likelihood of Recommending the Intervention to Friends or Sex Partners
Participants' likelihood of recommending the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session to friends or sex partners will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater likelihood of recommending the intervention to friends or sex partners.
Up to 32 weeks after participants complete the baseline survey
Secondary Outcomes (5)
Change in STI-related Knowledge
Pre-intervention score (from the baseline survey); Post-intervention score (from the satisfaction survey completed up to 32 weeks after participants complete the baseline survey)
Likelihood of Testing for Bacterial STIs at Least Annually
Up to 32 weeks after participants complete the baseline survey
Change in Self-efficacy for Specimen Self-collection
Pre-intervention score (from the baseline survey); Post-intervention score (from the satisfaction survey completed up to 32 weeks after participants complete the baseline survey)
Number of Participants That Test Negative or Positive for Gonorrhea, Chlamydia, and Syphilis
Up to 16 weeks after participants complete the baseline survey
Number of Participants That Initiate Treatment Within 1 Week of Receiving a Positive Test Result
Up to 28 weeks after participants complete the baseline survey
Study Arms (1)
Telehealth intervention
EXPERIMENTALParticipants will receive an MI-based telehealth intervention for bacterial STI screening.
Interventions
Participants will be asked to attend a pre-test live AV conferencing session, collect and return a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing, and attend a post-test live AV conferencing session.
Eligibility Criteria
You may qualify if:
- Individual self-reports identifying as a man (regardless of sex assigned at birth) in the eligibility screener
- Individual self-reports residing in a US state or territory in the eligibility screener
- Individual self-reports being physically located in a US state or territory when completing study activities in the eligibility screener
- Individual self-reports being greater than or equal to (≥)18 years of age in the eligibility screener
- Individual self-reports being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
- Individual self-reports having been diagnosed with HIV in the eligibility screener
- Individual self-reports having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
- Individual self-reports being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
- Individual self-reports being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
- Individual self-reports being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
- Individual provides valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
- Individual completes the baseline survey in order to receive the intervention
You may not qualify if:
- Individual self-reports not identifying as a man (regardless of sex assigned at birth) in the eligibility screener
- Individual self-reports not residing in a US state or territory in the eligibility screener
- Individual self-reports not being physically located in a US state or territory when completing study activities in the eligibility screener
- Individual self-reports not being ≥18 years of age in the eligibility screener
- Individual self-reports not being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
- Individual self-reports not having been diagnosed with HIV in the eligibility screener
- Individual self-reports not having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
- Individual self-reports not being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
- Individual self-reports not being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
- Individual self-reports not being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
- Individual does not provide valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
- Individual does not complete the baseline survey in order to receive the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Sharma A, Boyd S, Bonar EE. Feasibility and Acceptability of a Motivational Interviewing-Based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Protocol for a Sequential Explanatory Mixed Methods Study. JMIR Res Protoc. 2024 Aug 29;13:e64433. doi: 10.2196/64433.
PMID: 39208425DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Akshay Sharma
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Akshay Sharma, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, University of Michigan School of Nursing
Study Record Dates
First Submitted
October 20, 2023
First Posted
October 25, 2023
Study Start
April 19, 2024
Primary Completion
March 7, 2025
Study Completion
March 7, 2025
Last Updated
July 1, 2025
Results First Posted
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be made available within 6 months after analyses relating to the major aims of the proposed study have been completed and reported, and will remain available for at least 5 years.
- Access Criteria
- Creating an account on the ICPSR website.
Study results will be publicly reported through presentations at domestic and international conferences, and publications in peer-reviewed journals. Once analyses relating to the major aims of the proposed study have been completed and reported, the data will be deposited with the Inter-university Consortium for Political and Social Research (ICPSR) located at the University of Michigan. All confidentiality requirements will be followed as outlined on the website. ICPSR will make the data available to over 750 universities, government agencies, and other institutions, permitting other researchers to conduct secondary analyses. Data availability will be announced on the ICPSR website.